Meanwhile, GSK3α inhibition may be particularly beneficial in alleviating high-fat diet-induced hepatic steatosis by inhibiting de novo adipogenesis and further promoting glycogen storage [60,61]. The gene discussed is GSK3A; the disease is Hepatic steatosis.